QR kód

A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease

Introduction. The deregulated excessive pro-inflammatory cytokine secretion have a detrimental impact on the evolution of COVID-19, aggregating the tissue impairment, organ failure, and increasing the risk for death. Several studies have demonstrated the beneficial effect of Tocilizumab (TCZ) in re...

Celý popis

Uloženo v:
Hlavní autoři: Stela COJOCARU, Irina RUSSU, Galina BUTA, Sebastian BERSAN, Valentina POTÎNG-RAȘCOV, Natalia CULIUC, Lilia BABA
Médium: Artigo
Jazyk:Inglês
Vydáno: Asociatia de Biosiguranta si Biosecuritate 2023-09-01
Edice:One Health & Risk Management
Témata:
COVID-19
Cytokine Storm
Tocilizumab
On-line přístup:https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/374
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky